Italo-German competitiveness to-do list for Europe

German Chancellor Friedrich Merz and Italian Prime Minister Giorgia Meloni signed an updated Italo‑German Plan of Action prioritising ‘legislative self‑restraint’, simplification and a pro‑competitiveness regulatory mindset, and pledged to coordinate positions on Omnibus proposals to reduce burdens on start‑ups, SMEs and industry. The near‑term test is the EU’s Better Regulation reform (Call for Evidence open until Feb 4, with only 23 responses so far); if consultation and evaluation processes are relaxed, member states — including Italy and Germany — could lose leverage over the Commission’s agenda, raising regulatory risk for European businesses.

Analysis

Market structure: If Italy/Germany succeed in durable “legislative self‑restraint” and Omnibus simplification, beneficiaries will be EU SMEs, domestic-focused industrials and business-service providers via lower compliance costs (potentially 3–7% EBITDA tailwind over 12–24 months for high‑compliance SMEs). Losers in that scenario include RegTech, compliance consultancies and firms that sell regulatory complexity (legal/advisory revenue could compress 5–15%). If Better Regulation is instead relaxed to reduce stakeholder consultation, policy unpredictability rises, concentrating risk in highly regulated sectors (tech platforms, ESG/energy transition, financial services).

Risk assessment: Tail risks include a Commission-led unilateral push (low prob, high impact) that creates sudden sectoral regulatory shocks (eg. digital market rules or green taxonomy changes) causing short-dated equity drawdowns of 10–30% in targeted stocks. Time horizons: immediate (days) to watch Feb 4 Call-for‑Evidence close; short (1–6 months) for Omnibus trilogues; long (6–24 months) for enacted Better Regulation changes to filter through markets. Hidden dependencies: reduced consultation may paradoxically increase litigation and policy reversals, raising legal costs and volatility. Key catalysts: EC response to Call‑for‑Evidence (0–60 days), Council positions during Q2 2026, and public reaction from left‑leaning blocs.

Trade implications: Tactical long exposure to Italy/SME domestic plays and selected European industrial tech names, paired with optional hedges against regulatory shock, looks attractive. Use small size (1–3% portfolio exposures) with clear stop-losses tied to sovereign spread moves (+100bps Italy/Germany) or legislative milestones (Q2 trilogue failures). Options: buy 3‑month put spreads on broad Europe ETFs to cap tail risk; deploy calendar spreads around Council votes to monetize volatility.

Contrarian angles: Consensus underestimates the near-term positive cashflow boost to SMEs from administrative simplification — this is a measurable near-term earnings lever vs. the longer, binary risk of regulatory surprise. Reaction may be underdone in Italian small caps (EWI) and underpriced in ASML/Infineon for supply‑chain benefits from lower EU policy frictions. Unintended consequence: overzealous cutting of consultations could concentrate rule‑making inside the Commission, increasing regime risk and creating episodic selloffs; structure positions to capture steady gains while insuring against episodic losses.

Key Decisions for Investors

• Establish a 2–3% long position in iShares MSCI Italy ETF (EWI) with a 6–12 month horizon; target +15% upside if Omnibus simplification gains traction, trim to breakeven if Italy 10y spread vs Bund widens by >100bps or if Council rejects simplification motions.
• Allocate 1–2% long positions in ASML (ASML) and 1% in Infineon ADR (IFNNY) to play lower regulatory friction benefits for European industrial tech; set individual stops at -10% and take-profits at +15–20% over 3–9 months tied to Council/EC milestones.
• Implement downside protection: buy 3‑month put‑spread on Vanguard FTSE Europe ETF (VGK) sized to cover 1% portfolio exposure (buy 5% OTM put, sell 10% OTM put) to hedge a regulatory‑shock drawdown through Q2 2026.
• Pair trade: long 1.5% EWI / short 1% VGK to isolate Italy‑specific upside from EU‑wide movements; unwind if EWI underperforms VGK by >8% over a 3‑month rolling window or if Omnibus negotiations fail publicly.
• Watch and act on catalysts: if the EC publishes relaxation proposals or the Call‑for‑Evidence outcome by Feb 4 signals reduced consultation, reduce net long EU‑centric regulatory‑sensitive exposure by 30% within 7 trading days; if Council pushes back (Q2 2026), re‑increase exposure to capture simplification beta.